Amendment No 1. to the Asset Return and Termination Agreement, by and between Baxalta Incorporated and CTI BioPharma Corp., dated as of May 31, 2022
Contract Categories:
Business Operations
- Termination Agreements
EX-10.3 2 baxaltaamendmentno1fully.htm EX-10.3 baxaltaamendmentno1fully 
